Navigation Links
S*BIO and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors
Date:5/4/2010

es, M.D., president and CEO of Onyx. "Expanding our collaboration with S*BIO on these programs fits with Onyx's vision to invest in novel therapies and strengthens our position as an emerging oncology leader."

JAK2 inhibitors are implicated across a broad range of difficult-to-treat illnesses, including cancer and autoimmune diseases, in which patients have mutations and rearrangements of the JAK2 gene. SB1518 (ONX 0803) is a small molecule JAK2-selective kinase inhibitor, which has demonstrated activity against both the wild type JAK2 kinase and the JAK2 kinase with the V617F mutation. The V617F mutation is found in high frequencies in myeloproliferative disorders such as myelofibrosis (MF). It is estimated that approximately 50% of patients with MF possess the JAK2 mutation. SB1518 (ONX 0803) also provides new development pathways for other hematologic malignancies with mutations and rearrangements in the JAK2 gene.  At the recent American Society of Hematology annual meeting, investigators reported encouraging data for SB1518 (ONX 0803) in early stage clinical trials in myeoloproliferative and other hematologic disorders, such as leukemia and lymphoma.

Onyx can elect to exercise its exclusive options for SB1518 (ONX 0803) and SB1578 (ONX 0805) separately and independently at certain predetermined stages of development for each compound in all indications in the United States, Canada and Europe. S*BIO would retain rights to develop and commercialize SB1518 and SB1578 in the rest of the world.

About S*BIO Pte Ltd

S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC
'/>"/>

SOURCE S*BIO Pte Ltd; Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders
2. S*BIO Receives BioSpectrum Editors Choice, Emerging BioScience Company of Singapore Award
3. S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317
4. S*BIO Completes US$26 Million Equity Financing
5. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
6. Amylin Pharmaceuticals to Present at the Deutsche Bank 35th Annual Healthcare Conference
7. Merrimack Pharmaceuticals Promotes William Sullivan to Vice President of Finance
8. Merrimack Pharmaceuticals Recognized for Innovative Talent Management in HR Executive Magazine's ‘Best HR Ideas for 2010' Issue
9. Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals
10. OncoGenex Pharmaceuticals to Webcast Discussion of Financial Results for Fourth Quarter and Fiscal Year 2009
11. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015   Moleculera ... two-year, $300,000 matching grant from the Oklahoma Center ... This grant supports the development and clinical validation ... directed against neuronal antigens in patients experiencing neuropsychiatric ... Such panels are intended to assist physicians in ...
(Date:7/7/2015)... ... ... The global aptamers market is expected to reach $244.93 ... 17.89% between 2015 and 2020. The aptamer type segments included in this report ... is segmented into diagnostics, therapeutics development, R&D, and other applications. Diagnostics applications will ...
(Date:7/7/2015)... ND (PRWEB) , ... July 07, 2015 , ... CSM, ... executive team as Vice President of Finance. Morse has an extensive background in financial ... industries to the CSM team. In his new role, Morse will oversee all financial ...
(Date:7/7/2015)... ... July 07, 2015 , ... The Pistoia Alliance, a global, ... life science R&D, has attracted a number of new members from across the ... company joining as a Core member, and DNAnexus and Tessella as Participating members. ...
Breaking Biology Technology:Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 2Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin 3Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 2Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 3Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 4Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 5CSM Appoints Michael Morse as Vice President of Finance 2Pistoia Alliance Continues to Attract New Members 2
... 2012 PAC more accurately tracks true ... provider, Elsevier/Gold Standard , announced today an agreement with ... of a new price type, Predictive Acquisition Cost (PAC). ... need for a pricing standard that more closely tracks true ...
... Sales Performance, a global sales support organization providing consulting, ... $4 million to purchase and relocate to an expanded ... corridor. The company expects to create over 200 new ... next five years. In addition, through an innovative incentive ...
... The American Botanical Council (ABC) has announced the ... Literature Award in the reference and technical book category. ... of Botanical Medicines (CRC Press, 2011), has been ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The ABC James ...
Cached Biology Technology:Elsevier/Gold Standard Exclusive Publisher of New Predictive Drug Price Type 2Elsevier/Gold Standard Exclusive Publisher of New Predictive Drug Price Type 3City of Mason and Top Gun Sales Performance Announce $4 Million Investment In New Corporate Headquarters 2Herbal Microscopy Book Receives American Botanical Council's James A. Duke Book Award 2Herbal Microscopy Book Receives American Botanical Council's James A. Duke Book Award 3Herbal Microscopy Book Receives American Botanical Council's James A. Duke Book Award 4Herbal Microscopy Book Receives American Botanical Council's James A. Duke Book Award 5
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., a ... by the United States Patent and Trademark Office (USPTO) ... process leverages TAKE Solutions, Clinical Accelerators to reduce the ... (when compared to standardization without the accelerators), thus reducing ... At the heart of the patented ...
(Date:6/24/2015)... Calif. , June 24, 2015  Synaptics ... of human interface solutions, today announced that Sharp ... to provide secure authentication for its latest flagship ... reached more than 200 million shipments of its ... Sharp reinforces Synaptics, strength, scalability and leadership in ...
(Date:6/23/2015)... MINNETONKA, Minn. , June 23, 2015 /PRNewswire/ ... technology company that supports the entire spectrum of ... iMedNet ™ , the company,s ... has been awarded a Silver 2015 Stevie® Award ... the Health Products & Services Website category.  The ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... when one master gene actually suppresses the action of ... report that appears online in the journal Proceedings of ... of bone and cartilage cells that are differentiated from ... associate professor of molecular and human genetics at BCM, ...
... stroke in the U.S. over the past 50 years has ... a study in the December 27 issue of JAMA. , ... more than 750,000 new strokes occurring each year in the ... behind heart disease and cancer and the leading neurologic cause ...
... multiplied and differentiated into brain cells on a new ... more like a living body than any other cell ... will report the invention-which may one day replace the ... issue of the PLoS ONE. Shuguang Zhang, associate director ...
Cached Biology News:Signaling for cartilage 2Incidence of stroke decreases over last 50 years 2MIT creates 3-D scaffold for growing stem cells 2MIT creates 3-D scaffold for growing stem cells 3
Human Aminopeptidase P2/XPNPEP2 Affinity Purified PAb ENTREZ GeneID: 7512...
Collected from 8-12 week old sexually mature rats. Pricing: $100/unit for 1 - 10 units...
PlusOne Acrylamide PAGE, 1 kg. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Gel Casting Chemicals....
... RNA Quantitation Kit is one of ... the quantitation of RNA in solution. ... more sensitive than absorbance measurements. As ... detected with fluorescence microplate readers and ...
Biology Products: